Annals of B Pod: Anti-Xa Overdose
Taming the SRU
FEBRUARY 12, 2024
The patient is agitated on a backboard with C-collar in place. DISCUSSION Epidemiology and Background Rivaroxaban, along with other direct oral anticoagulants (DOACs), has become a mainstay of treatment for pro-thrombotic conditions since 2011. [1] BMC Pharmacol Toxicol. May 2; 19(1): 19. Schulman, S et al. J Thromb Haemost. Jan; 8(1): 202-4.
Let's personalize your content